These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 16230145)
1. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer. Ochiai A; Fritsche HA; Babaian RJ Urology; 2005 Oct; 66(4):819-23. PubMed ID: 16230145 [TBL] [Abstract][Full Text] [Related]
3. Serum prostate-specific antigen is better correlated to body surface area than body mass index in a population of healthy Korean men. Song M; Doo SW; Yang WJ; Song YS; Kim Y Int J Urol; 2010 Jun; 17(6):580-3. PubMed ID: 20370844 [TBL] [Abstract][Full Text] [Related]
4. The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum prostate specific antigen levels in men without clinically detectable prostate cancer. Ornstein DK; Smith DS; Humphrey PA; Catalona WJ J Urol; 1998 Apr; 159(4):1234-7. PubMed ID: 9507843 [TBL] [Abstract][Full Text] [Related]
5. Value of prostate-specific antigen (PSA) mass ratio in the detection of prostate cancer in men with PSA levels of ≤10 ng/mL. Hong SK; Oh JJ; Byun SS; Hwang SI; Choo MS; Lee SE BJU Int; 2012 Jul; 110(2 Pt 2):E81-5. PubMed ID: 22093144 [TBL] [Abstract][Full Text] [Related]
6. Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old. Loeb S; Roehl KA; Antenor JA; Catalona WJ; Suarez BK; Nadler RB Urology; 2006 Feb; 67(2):316-20. PubMed ID: 16442597 [TBL] [Abstract][Full Text] [Related]
7. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Hammarsten J; Högstedt B Eur J Cancer; 2005 Dec; 41(18):2887-95. PubMed ID: 16243513 [TBL] [Abstract][Full Text] [Related]
8. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme. Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847 [TBL] [Abstract][Full Text] [Related]
9. Biopsy indication--a predictor of pathologic stage among men with preoperative serum PSA levels of 4.0 ng/mL or less and T1c disease. Freedland SJ; Mangold LA; Epstein JI; Partin AW Urology; 2004 May; 63(5):887-91. PubMed ID: 15134972 [TBL] [Abstract][Full Text] [Related]
10. Is there a role for serum human tissue kallikrein in detection of prostate cancer? Ochiai A; Shukla A; Davis JW; Fritsche HA; Bhadkamkar V; Babaian RJ Urology; 2007 Sep; 70(3):519-22. PubMed ID: 17905108 [TBL] [Abstract][Full Text] [Related]
11. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic. Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334 [TBL] [Abstract][Full Text] [Related]
12. Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study. Chia SE; Lau WK; Chin CM; Tan J; Ho SH; Lee J; Cheng C BJU Int; 2009 Jun; 103(11):1487-91. PubMed ID: 19076145 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the serum testosterone to prostate-specific antigen ratio as a predictor of prostate cancer risk. Morote J; Planas J; Ramirez C; Gómez E; Raventós CX; Placer J; Catalán R; de Torres IM BJU Int; 2010 Feb; 105(4):481-4. PubMed ID: 19681902 [TBL] [Abstract][Full Text] [Related]
14. Association between serum prostate-specific antigen level, liver function tests and lipid profile in healthy men. Han JH; Chang IH; Ahn SH; Kwon OJ; Bang SH; Choi NY; Park SW; Myung SC; Kim HW BJU Int; 2008 Nov; 102(9):1097-101. PubMed ID: 18522630 [TBL] [Abstract][Full Text] [Related]
15. [Relationship between serum prostate-specific antigen levels and body mass index in Beijing men over 50 years of age]. Wang Y; Zhou Z; Tian Y; Shao Q; Chen S; Hong BF; Zhang XH; Ren XH; Sun WX; Wang ZW; Na YQ Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1681-3. PubMed ID: 19957525 [TBL] [Abstract][Full Text] [Related]
16. Contemporary prostate cancer prevalence among T1c biopsy-referred men with a prostate-specific antigen level < or = 4.0 ng per milliliter. Ahyai SA; Graefen M; Steuber T; Haese A; Schlomm T; Walz J; Köllermann J; Briganti A; Zacharias M; Friedrich MG; Karakiewicz PI; Montorsi F; Huland H; Chun FK Eur Urol; 2008 Apr; 53(4):750-7. PubMed ID: 17964070 [TBL] [Abstract][Full Text] [Related]
17. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution. Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809 [TBL] [Abstract][Full Text] [Related]
18. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men. Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477 [TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor 1, chromogranin A and prostate specific antigen serum levels in prostate cancer patients and controls. Marszalek M; Wachter J; Ponholzer A; Leitha T; Rauchenwald M; Madersbacher S Eur Urol; 2005 Jul; 48(1):34-9. PubMed ID: 15967249 [TBL] [Abstract][Full Text] [Related]
20. Age-specific reference levels of serum prostate-specific antigen and prostate volume in healthy Arab men. Kehinde EO; Mojiminiyi OA; Sheikh M; Al-Awadi KA; Daar AS; Al-Hunayan A; Anim JT; Al-Sumait AA BJU Int; 2005 Aug; 96(3):308-12. PubMed ID: 16042719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]